Abstract
Cardiovascular disease is the main cause of death in the United States. Although it is recognized that moderate intensity long-term exercise can decrease the chances of dying from cardiovascular disease by favorably modifying risk factors such as hypertension, obesity, hyperlipidemia, and insulin resistance, physical activity also enhances longevity by mechanisms independent of these risk factors. This review briefly summarizes what is known about the inflammatory nature of atherosclerosis and how long-term aerobic exercise can reduce the atherogenic activity of endothelial cells, blood mononuclear cells, and adipose tissue.
Keywords: Exercise, cardiovascular disease, cardiorespiratory fitness, atherogenesis, vascular endothelial cells, peripheral blood mononuclear cells, adipose tissue, inflammation, cell-mediated immunity, hypertension, obesity, hyperlipidemia, insulin resistance, immunopathogenesis, vascular endothelial cells (VEC), Chlamydia pneumoniae, cytomegalovirus, heat shock protein 60 (Hsp 60), chemokines, prostacyclin PGI2, adrenomedullin, granulopoiesis, immunogens, metalloproteinases, phosphorylation, eNOS protein, adipocytes, lymphocytes, fibroblasts, adipokines, monocytes
Cardiovascular & Hematological Disorders-Drug Targets
Title: Exercise and Cardiovascular Disease
Volume: 10 Issue: 4
Author(s): J. Kelly Smith
Affiliation:
Keywords: Exercise, cardiovascular disease, cardiorespiratory fitness, atherogenesis, vascular endothelial cells, peripheral blood mononuclear cells, adipose tissue, inflammation, cell-mediated immunity, hypertension, obesity, hyperlipidemia, insulin resistance, immunopathogenesis, vascular endothelial cells (VEC), Chlamydia pneumoniae, cytomegalovirus, heat shock protein 60 (Hsp 60), chemokines, prostacyclin PGI2, adrenomedullin, granulopoiesis, immunogens, metalloproteinases, phosphorylation, eNOS protein, adipocytes, lymphocytes, fibroblasts, adipokines, monocytes
Abstract: Cardiovascular disease is the main cause of death in the United States. Although it is recognized that moderate intensity long-term exercise can decrease the chances of dying from cardiovascular disease by favorably modifying risk factors such as hypertension, obesity, hyperlipidemia, and insulin resistance, physical activity also enhances longevity by mechanisms independent of these risk factors. This review briefly summarizes what is known about the inflammatory nature of atherosclerosis and how long-term aerobic exercise can reduce the atherogenic activity of endothelial cells, blood mononuclear cells, and adipose tissue.
Export Options
About this article
Cite this article as:
Kelly Smith J., Exercise and Cardiovascular Disease, Cardiovascular & Hematological Disorders-Drug Targets 2010; 10 (4) . https://dx.doi.org/10.2174/187152910793743823
DOI https://dx.doi.org/10.2174/187152910793743823 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals Identification of Canonical Transient Receptor Potential (TRPC) Channel Proteins in Native Vascular Smooth Muscle Cells
Current Medicinal Chemistry Effects of Estrogens on Atherogenesis
Current Vascular Pharmacology Determination of Residual Solvents in Eprosartan Mesylate by Static Headspace Gas Chromatographic Method Optimized by Response Surface Methodology
Current Pharmaceutical Analysis Radiation-Induced Lung Injury Following Therapy for Thoracic Malignancy
Current Respiratory Medicine Reviews Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients
Current Pharmaceutical Design Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial [Hot Topic: Phosphodiesterase 5 Inhibitors: Pharmacology and Therapeutic Perspectives (Executive Editor: Giuseppe Barbaro)]
Current Pharmaceutical Design Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Domperidone and Long QT Syndrome
Current Drug Safety Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Nosocomial Infections and Antimicrobial Treatment in Coiled Patients with Aneurysmal Subarachnoid Hemorrhage
Current Drug Targets Antioxidant Capacity, Phytochemical Analysis and Identification of Active Compounds in Anchomanes difformis
The Natural Products Journal Synthesis of 1,2,4-triazole Derivatives: Binding Properties on Endothelin Receptors
Medicinal Chemistry Rheumatoid Nodulosis in a Patient with Lupus Erythematosus: Case Report and Review
Current Rheumatology Reviews Virgin Olive Oil and Hypertension
Current Vascular Pharmacology A High Burden of Ischemic Stroke in Regions of Eastern/Central Europe is Largely Due to Modifiable Risk Factors
Current Neurovascular Research Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Cardiovascular Risk Factors and Dietary Patterns
Current Nutrition & Food Science